Genoway modified animal developer wins US contract worth up to 2 mln usd |
|
|
|
Published
:
Wed, 17 Oct 2007 10:28
|
PARIS (Thomson Financial) - Genoway, a French biotechnology company which develops genetically modified animal models, said it won a contract worth up to 2 mln usd from a leading US-based biopharmaceutical company.Under the 2-year agreement, Genoway will provide customized genetically modified mouse lines tailored to researchers needs.The agreement can be increased to include additional models, the company said.'This contract is the second multi-million dollar deal of the year for Genoway,' Alexandre Fraichard, the CEO, said in a statement.In May, Genoway was awarded funding of 1.1 mln eur by the German National Genome Research Network to develop mouse models for a consortium focussing on human diseases.At 11.15 am, Genoway shares were up 0.65 eur or 10.92 pct at 6.60 eur as the Next-150 index gained 9.85 points pr 0.51 pct to 1,939.54.Andrew.Newby@Thomson.coman/tcCOPYRIGHTCopyright Thomson Financial News Limited 2007. All rights reserved.The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
|
|
|
|
Print this Story
Fast Search & Transfer takes contract wins to six in three days 